Filing Flows

Filing Flows › National Health Investors (NHI) › Q3 2025

National Health Investors (NHI) Q3 2025 earnings results (third quarter 2025)

10-Q filed Nov 6, 2025

National Health Investors (NHI) reported revenue of $89.8M for the third quarter 2025 (Q3 2025), +8% from a year earlier and -0.9% from the quarter before. Operating margin was 36.1%, net earnings $32.9M (36.6% of revenue).

Revenue$89.8M
Year over year+8%
Quarter over quarter-0.9%
Operating margin36.1%
Net earnings$32.9M

National Health Investors, Q3 2025: revenue $89.8M (+8% year over year), operating margin 36.1%, net earnings $32.9M, operating cash flow $62.5M. The chart follows the revenue to costs, profit and cash.

Q3 2025AmountQ/QY/Y
Revenue$89.8M-0.9%+8%
Operating profit$32.5M-11%+15%
Net earnings$32.9M-11%+15%
Operating cash flow$62.5M+5%+29%

What changed

Revenue was $89.8M in Q3 2025, up 8% year over year and down 1% from the previous quarter.

Operating profit was $32.5M, a 36.1% margin (up 2.1 points year over year). Of the extra revenue versus a year earlier, 61% reached operating profit, above the 34% margin then. Total costs grew 5% against revenue growth of 8%. The fastest-growing cost line was General & admin (+31%). Net earnings were $32.9M, up 15% year over year ($32.5M including minority interests, which bore $384K of losses). The effective tax rate was 0.0%.

Operating cash flow was $62.5M (up 29% year over year), 193% of net earnings. Non-cash charges added back $20.2M of depreciation and $1.0M of share-based compensation. Working capital and other items added $8.9M.

Questions

What was National Health Investors' revenue in the third quarter 2025?

National Health Investors (NHI) reported revenue of $89.8M for the third quarter 2025 (Q3 2025), +8% from a year earlier and -0.9% from the quarter before.

Was National Health Investors profitable in the third quarter 2025?

Operating profit was $32.5M (36.1% of revenue) and net earnings $32.9M.

Open the interactive Sankey →

Source: National Health Investors 10-Q on SEC EDGAR.